| Net Cash Provided by (Used in) Operating Activities |
-432K |
USD |
-33% |
Q4 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
0 |
USD |
-100% |
Q4 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Q4 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
600M |
shares |
0% |
Q2 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
470M |
shares |
+0.63% |
Q2 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
417K |
USD |
-75.7% |
Q2 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Q4 2024 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
2.86M |
USD |
|
Q2 2025 |
Q3 2025 |
| Depreciation |
39.7K |
USD |
-5.48% |
Q2 2025 |
Q3 2025 |
| Property, Plant and Equipment, Gross |
249K |
USD |
+1.22% |
Q2 2025 |
Q3 2025 |
| Deferred Income Tax Expense (Benefit) |
0 |
USD |
|
Q4 2024 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
2.86M |
USD |
|
Q2 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
100M |
shares |
0% |
Q2 2025 |
Q3 2025 |
| Additional Paid in Capital |
37.1M |
USD |
+3.72% |
Q2 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q2 2025 |
Q3 2025 |
| Interest Expense |
216K |
USD |
-91.1% |
Q2 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q3 2025 |